Lucid Diagnostics Inc expected to post a loss of 7 cents a share - Earnings Preview

Lucid Diagnostics

10/08/2026 23:10

Lucid Diagnostics Inc LUCD.OQ LUCD.O is expected to  show a rise in quarterly revenue when it reports  results on August 12 for the period ending June 30 2026
The New York City-based  company is expected to report a 23.9% increase in revenue to $1.44 million from $1.16 million a year ago, according to the mean estimate from 5 analysts, based on LSEG data.
​LSEG's mean analyst estimate for Lucid Diagnostics Inc is for a loss of 7 cents per share. 
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."  
The mean earnings estimate of analysts was unchanged in the last three months. ​
Wall Street's median 12-month price target for Lucid Diagnostics Inc is $3.00, about 210.2% above its last closing price of $0.97
Previous quarterly performance (using preferred earnings measure in US dollars). ​
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE 
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2026
-0.08
-0.08
-0.17
Missed
-104.8
Dec. 31 2026
-0.10
-0.10
Met
0
Sep. 30 2025
-0.11
-0.11
-0.10
Beat
9.3​
Jun. 30 2025
-0.12
-0.12
-0.08
Beat
33.9
​​Mar. 31 2025
-0.16
-0.16
-0.52
Missed
-228.7
Dec. 31 2024
-0.19
-0.18
Beat
5.3​
Sep. 30 2024
-0.22
-0.22
-0.25
Missed
-13.6
Jun. 30 2024
-0.22
-0.22
-0.23
Missed
-4.5
This summary was machine generated August 10 at 22:10 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)